Assessment of Azeliragon QTc Liability Through Integrated, Model-Based Concentration QTc Analysis.
Saved in:
| Title: | Assessment of Azeliragon QTc Liability Through Integrated, Model-Based Concentration QTc Analysis. |
|---|---|
| Authors: | Burstein AH; vTv Therapeutics LLC, High Point, NC, USA., Brantley SJ; Nuventra, Inc., Durham, NC, USA., Dunn I; vTv Therapeutics LLC, High Point, NC, USA., Altstiel LD; Formerly vTv Therapeutics LLC, High Point, NC, USA., Schmith V; vTv Therapeutics LLC, High Point, NC, USA. |
| Source: | Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 May; Vol. 8 (4), pp. 426-435. Date of Electronic Publication: 2019 Apr 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30934161 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Assessment of Azeliragon QTc Liability Through Integrated, Model-Based Concentration QTc Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burstein+AH%22">Burstein AH</searchLink>; vTv Therapeutics LLC, High Point, NC, USA.<br /><searchLink fieldCode="AU" term="%22Brantley+SJ%22">Brantley SJ</searchLink>; Nuventra, Inc., Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Dunn+I%22">Dunn I</searchLink>; vTv Therapeutics LLC, High Point, NC, USA.<br /><searchLink fieldCode="AU" term="%22Altstiel+LD%22">Altstiel LD</searchLink>; Formerly vTv Therapeutics LLC, High Point, NC, USA.<br /><searchLink fieldCode="AU" term="%22Schmith+V%22">Schmith V</searchLink>; vTv Therapeutics LLC, High Point, NC, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101572899%22">Clinical pharmacology in drug development</searchLink> [Clin Pharmacol Drug Dev] 2019 May; Vol. 8 (4), pp. 426-435. <i>Date of Electronic Publication: </i>2019 Apr 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2160-7648 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222160763X%22">2160763X </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Drug Dev <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30934161 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpdd.689 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 426 Titles: – TitleFull: Assessment of Azeliragon QTc Liability Through Integrated, Model-Based Concentration QTc Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burstein AH – PersonEntity: Name: NameFull: Brantley SJ – PersonEntity: Name: NameFull: Dunn I – PersonEntity: Name: NameFull: Altstiel LD – PersonEntity: Name: NameFull: Schmith V IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2019 May Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2160-7648 Numbering: – Type: volume Value: 8 – Type: issue Value: 4 Titles: – TitleFull: Clinical pharmacology in drug development Type: main |
| ResultId | 1 |
